Skip to main content
. 2012 Nov 14;2012(11):CD008079. doi: 10.1002/14651858.CD008079.pub2

Analysis 1.28.

Analysis 1.28

Comparison 1 Anti‐leukaemic therapy plus anti‐CD20 versus anti‐leukaemic therapy alone (anti‐leukaemic therapy identical in both groups), Outcome 28 Grade 3/4 AEs ‐ overall analysis.